Please login to the form below

Not currently logged in
Email:
Password:

PwC

This page shows the latest PwC news and features for those working in and with pharma, biotech and healthcare.

Roche biggest pharma R&D spender in PwC survey

Roche biggest pharma R&D spender in PwC survey

The data comes from PwC Strategy &unit’s 2017 Global Innovation 1000 study, which this year focuses on the potential impact of rising economic nationalism and an increasingly inward-looking political ... PwC expects, such creating “robust, autonomous

Latest news

  • La La Land? The myth of multichannel excellence La La Land? The myth of multichannel excellence

    58% of customers prefer to receive marketing promotions via email over social, print or text message (PwC).

  • Celebrating excellence Celebrating excellence

    This year entries were assessed by a panel of experienced, independent industry judges from the likes of EY, Quintiles, Engage, PA Consulting, Cello Health Consultancy and PwC, as well as patient

  • AbbVie takes Company of the Year at PMEA 2015 AbbVie takes Company of the Year at PMEA 2015

    This year entries were assessed by an experienced panel of experienced, independent industry judges from the likes of EY, Quintiles, Engage, PA Consulting, Cello Health Consultancy and PWC, as well as

  • PMEA 2015 now open for entry PMEA 2015 now open for entry

    Entries will be assessed by an experienced panel of experienced, independent industry judges from the likes of EY, Quintiles, Engage, PA Consulting, Cello Health Consultancy and PWC, as well as patient

  • Healthcare boundaries 'being erased,' says PwC Healthcare boundaries 'being erased,' says PwC

    and erasing healthcare boundaries as they "enable care anywhere," according to PricewaterhouseCoopers (PwC). ... In emerging markets surveyed by PwC - namely Brazil, China, India, South Africa and Turkey - more than half (54%) of respondents expect that

More from news
Approximately 0 fully matching, plus 41 partially matching documents found.

Latest Intelligence

  • Lonely planet: why there is dwindling value in pharma travelling alone Lonely planet: why there is dwindling value in pharma travelling alone

    Almost a decade ago, PwC predicted that by 2020, no pharmaceutical company would be able to ‘profit alone’. ... With the 2020 milestone almost upon us, evidence suggests that the central prediction of the PwC report has proved to be correct.

  • How pharma can unlock the potential of influencer marketing How pharma can unlock the potential of influencer marketing

    The statistics are pretty compelling. According to Pew Research Centre and PwC Health Research:.

  • Pushing the accelerator Pushing the accelerator

    Take the case of a pharmaceutical company that worked with PwC to find out why a promising cancer drug kept failing in some phase III trials and to pinpoint suitable patient

  • Deal Watch December 2015 Deal Watch December 2015

    December saw the release of reports by two of the top accountancy and consulting groups, PWC and Deloitte. ... PWC's report Top Health Industry Issues of 2016 - Thriving in the New Health Economy describes, among many other interesting points, that 2016

  • Delivering accessible healthcare Delivering accessible healthcare

    This article first appeared in Evolution or Revolution? by Merck Consumer Health  . Partner, Pharmaceuticals &Lifesciences Practice, PwC. 19th May 2015.

More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest appointments

  • BMS appoints new commercial leader, Davies joins Eisai and more BMS appoints new commercial leader, Davies joins Eisai and more

    Britten has held senior financial leadership roles prior to this, and aside from her role at AstraZeneca, she has served as director of M&A at PwC.

  • Genoscience Pharma expands board of directors Genoscience Pharma expands board of directors

    He most recently served as Pharmcyclics' chief financial officer and treasurer and has also held management positions at ZELTIQ Aesthetics and PriceWaterhouseCoopers, where he worked in PwC's San Jose office

  • PwC appoints Issy Corbett as healthcare M&A partner PwC appoints Issy Corbett as healthcare M&A partner

    Andrew McKechnie, partner and head of healthcare deals at PwC, said: “Issy's experience and reputation in healthcare M&A is market-leading. ... In his new role, Corbett will lead PwC's healthcare M&A team, working with the company's public sector

  • Steve Arlington joins Pistoia Alliance Steve Arlington joins Pistoia Alliance

    Former PwC partner takes up role as the innovationnon-profit's president. The Pistoia Alliance has appointed former PwC partner Steve Arlington as its new president. ... Arlington was previously global lead partner of pharmaceuticals and life sciences

  • Adaptimmune appoints Lawrence Alleva to its board Adaptimmune appoints Lawrence Alleva to its board

    The former PwC partner will also chair its boardaudit committee. Adaptimmune has appointed former PwC partner Lawrence (Larry) Alleva to its board of directors as an independent, non-executive director. ... Alleva spent 39 years with

More from appointments
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics